Jan Netolicky

Jan Netolicky

Auto-generated profile, based on publicly available information

Jan Netolicky

Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czechia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2026 in BMC Oral Health
Verified
Journal Article
Open access
JLJan Liska
Jan Liska
NMNikoleta Molnarova
Nikoleta Molnarova
JNJan Netolicky
Jan Netolicky
PHPetra Hauerova
Petra Hauerova
MKMarie Karlikova
Marie Karlikova
VLVeronika Liskova
Veronika Liskova
The management of follow-up in proliferative verrucous leukoplakia (PVL) cases remains highly challenging due to the absence of established etiological factors and limited understanding of disease progression. The aim of this study was to identify optimal biomarkers of PVL behavior to facilitate decision-making in complex therapeutic management. Salivary levels of matrix metalloproteinases (MMPs) were evaluated in 54 confirmed PVL cases. All patients underwent follow-up at Oral Medicine Department, Dentistry Clinic at University Hospital Pilsen. Unstimulated saliva samples were collected and analyzed for MMP-1, -2, -3, -7, and − 9 concentrations. Criteria for PVL stability and progression were defined. Disease progression in individual cases was retrospectively correlated with salivary MMP levels to identify optimal prognostic markers. Assessment of PVL progression and stability was performed 6 months after salivary MMP sampling. Progression was observed in 63% of patients (34/54). Significant associations between elevated salivary MMP levels and PVL progression were confirmed for four of the five MMPs tested. MMP-1, -3, -7, and − 9 emerged as promising markers. A combination of MMP-3 and MMP-7 demonstrated the best prognostic performance, with a sensitivity of approximately 79.5% and a specificity of 89%. This is the first study to evaluate salivary MMPs for PVL monitoring. Our findings confirm an association between elevated salivary MMP levels and an increased risk of PVL progression. This non-invasive approach may improve clinical management and follow-up of patients with PVL. The online version contains supplementary material available at 10.1186/s12903-026-08211-y.

30 September 2026 in Dental and Medical Problems
Verified
Journal Article
Open access
JLJan Liska
Jan Liska
VLVeronika Liskova
Veronika Liskova
NMNikoleta Molnarova
Nikoleta Molnarova
OTOndrej Topolcan
Ondrej Topolcan
JNJan Netolicky
Jan Netolicky
DKDenisa Kacerovska
Denisa Kacerovska